How government policies will drive China’s robotic surgery market Surgical robotics technology adoption is expected to… Orthopaedic & Spine Surgery | Robotic surgery | Surgical device | Uncategorised | Asia | Orthopaedic & Spine Surgery | Robotic surgery | Surgical Gateway
Building a market access blueprint for lung cancer diagnostics in Asia-Pacific Lung cancer is the leading cause of cancer mortality in the… Cancer diagnostics | Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Global | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx)
Launching a new value proposition for core lab solutions An IVD multinational company is preparing to roll out a new… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Americas | Asia | Europe | Global | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway
Reimbursement of robotic surgery expected to increase in Asia Reimbursement and the affordability of digital health… Orthopaedic & Spine Surgery | Robotic surgery | Surgical device | Asia | Orthopaedic & Spine Surgery | Robotic surgery | Surgical Gateway
How government policies will drive South Korea’s robotic surgery market Digital technology is emerging as a long-term driver of… Orthopaedic & Spine Surgery | Robotic surgery | Surgical device | Asia | Orthopaedic & Spine Surgery | Robotic surgery | Surgical Gateway
How Indonesia’s healthcare transformation will impact its IVD market Indonesia’s in-vitro diagnostics (IVD) market will recover… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Asia | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
APAC IVD market to shrink by 2026 as demand for covid-19 testing cools further The Asia-Pacific (APAC) in-vitro diagnostics (IVD) market… In-vitro diagnostics | Asia | IVD Gateway
Asia-Pacific infectious disease diagnostics market trends In Asia-Pacific (APAC), many countries continue to build up… In-vitro diagnostics | Infectious Diseases Testing Monitor | Uncategorised | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Elective surgery volume expected to make full recovery in 2023-24 Clearstate estimates that it will take until early 2024 to… Cardiovascular surgery | Orthopaedic & Spine Surgery | Surgical device | Asia | Cardiovascular Surgery | Orthopaedic & Spine Surgery | Surgical Gateway | Surgical Procedure Volume Segmentation
Highlights from the 2022 APAC surgical device market briefing Growth opportunities for surgical device companies are… General surgery | Surgical device | Asia | General Surgery | Surgical Gateway
Knee replacement innovations in Asia Pacific With longer life expectancies in APAC, there is an… General surgery | Surgical device | Asia | General Surgery | Surgical Gateway | The Gateway
Cardiac biomarker testing market outlook in Asia-Pacific The incidence of cardiovascular diseases (CVD) in… In-vitro diagnostics | Point-of-care testing (POCT) | Asia | IVD Gateway | Point-of-care testing (POCT)